Medicare Enrolled

Dr. Daniel Rootman, MSC MD FRCSC

Ophthalmology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
100 STEIN PLZ, Los Angeles, CA 90095
6268174747
In practice since 2012 (13 years)
NPI: 1871849091 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rootman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rootman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rootman

Dr. Daniel Rootman is an ophthalmology specialist in Los Angeles, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Rootman performed 7,682 Medicare services across 867 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rootman received a total of $186,432 from 12 pharmaceutical and/or device companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rootman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 12% volume in CA $186,432 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,682
Medicare services
Top 12% in CA for ophthalmology
867
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~591 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
4,698 $5 $38
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
1,910 $4 $22
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
505 $74 $580
Eye photography
Photographic imaging of the interior structures of the eye.
204 $20 $246
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
76 $158 $1,215
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
55 $89 $864
Nasal tear duct probing
A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye.
45 $124 $1,000
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $108 $858
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
29 $52 $460
Eyelid drooping or paralysis tissue removal
A surgical procedure to remove tissue, muscle, and membrane to correct eyelid drooping or paralysis.
22 $477 $4,479
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $128 $1,085
Removal of excessive skin and fat of upper eyelid 19 $708 $6,057
Temporary closure of eyelids by suture 18 $45 $1,208
Eyelid biopsy
A procedure to remove a small sample of tissue from the eyelid for laboratory examination.
16 $156 $1,020
Endoscopic tear duct incision
A surgical procedure to open a tear duct using an endoscope. The endoscope allows the surgeon to view the inside of the duct during the incision.
14 $574 $4,556
Endoscopic partial removal of nasal sinus
A surgical procedure to partially remove tissue from a nasal sinus using an endoscope, a thin tube with a camera inserted through the nose.
11 $174 $2,040
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$186,432
Total received (2018-2024)
Avg $26,633/year across 7 years
Top 3% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
12
Companies
223
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$144,009 (77.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$41,621 (22.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$803 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$34,855
2023
$57,328
2022
$20,389
2021
$40,693
2020
$19,513
2019
$13,590
2018
$64

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$21,911
ARGENX US, INC.
$12,797
ABBVIE INC.
$147
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$144,009
Amgen Inc.
$21,911
ARGENX US, INC.
$17,691
Celularity Inc.
$2,019
Merz North America, Inc.
$227
ABBVIE INC.
$147
Genentech USA, Inc.
$144
Mallinckrodt Hospital Products Inc.
$100
AXOGEN
$89
MERZ NORTH AMERICA, INC.
$50
Merz Pharmaceuticals, LLC
$32
Medtronic USA, Inc.
$14
Top 3 companies account for 98.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Avance Nerve Graft · Erivedge · LEGEND · TEPEZZA · VYVGART · XEOMIN · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for ophthalmology in CA.

Looking for an ophthalmology specialist in Los Angeles?
Compare ophthalmologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
709
Per 100K population
7.2
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rootman is a mixed practice specialist, with above-average Medicare volume (top 12% in CA), with speaking/promotional industry engagement in the top 3% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rootman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rootman performed 4,698 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rootman receive payments from pharmaceutical companies?
Yes. Dr. Rootman received a total of $186,432 from 12 companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rootman's costs compare to other ophthalmologists in Los Angeles?
Dr. Rootman's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rootman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →